Showing results (61-70 of 98) with videos related to

Sort By:
Pageof 10
Endocrine-Related Cancer|September 17, 2015
Efficacy of octreotide long-acting repeatable in neuroendocrine tumors: RADIANT-2 placebo arm post hoc analysisJonathan R Strosberg, James C Yao, Emilio Bajetta, et al.
American Journal of Clinical Oncology|February 23, 2013
Chronomodulated capecitabine and adjuvant radiation in intermediate-risk to high-risk rectal cancer: a phase II studyEmilio Bajetta, Filippo Pietrantonio, Roberto Buzzoni, et al.
Cancers|September 27, 2014
Circulating biomarkers in advanced colorectal cancer patients randomly assigned to three bevacizumab-based regimensAntonia Martinetti, Rosalba Miceli, Elisa Sottotetti, et al.
Cancer|April 23, 2014
Everolimus in combination with octreotide long-acting repeatable in a first-line setting for patients with neuroendocrine tumors: an ITMO group studyEmilio Bajetta, Laura Catena, Nicola Fazio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 30, 2010
Bevacizumab plus fotemustine as first-line treatment in metastatic melanoma patients: clinical activity and modulation of angiogenesis and lymphangiogenesis factorsMichele Del Vecchio, Roberta Mortarini, Stefania Canova, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 25, 2010
Palonosetron in combination with 1-day versus 3-day dexamethasone for prevention of nausea and vomiting following moderately emetogenic chemotherapy: a randomized, multicenter, phase III trialLuigi Celio, Sergio Frustaci, Angela Denaro, et al.
Endocrine-Related Cancer|December 23, 2004
Prospective evaluation of estrogen receptor-beta in predicting response to neoadjuvant antiestrogen therapy in elderly breast cancer patientsVera Cappelletti, Luigi Celio, Emilio Bajetta, et al.
Anticancer Research|August 21, 2003
Bone turnover markers and insulin-like growth factor components in metastatic breast cancer: results from a randomised trial of exemestane vs megestrol acetateAntonia Martinetti, Nicoletta Zilembo, Leonardo Ferrari, et al.
Endocrine-Related Cancer|May 30, 2008
Patterns and changes in gene expression following neo-adjuvant anti-estrogen treatment in estrogen receptor-positive breast cancerVera Cappelletti, Manuela Gariboldi, Loris De Cecco, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 8, 2013
Phase II study of everolimus in patients with metastatic colorectal adenocarcinoma previously treated with bevacizumab-, fluoropyrimidine-, oxaliplatin-, and irinotecan-based regimensKimmie Ng, Josep Tabernero, Jimmy Hwang, et al.
Pageof 10